|
PSCI-22-025 |
S1914 A Randomized Phase III Trial of Induction/Consolidation Atezolizumab (NSC #783608) + SBRT versus SBRT Alone in High Risk, Early Stage NSCLC |
|
PSCI-22-026 |
A Randomized Phase II/III Trial of Modern Immunotherapy Based Systemic Therapy With or Without SBRT for PD-L1-Negative, Advanced Non-Small Cell Lung Cancer |
|
PSCI-22-036 |
Neuro-pharmacological properties of repurposed ketoconazole in glioblastomas: A Phase 0 clinical trial |
|
PSCI-22-042 |
A Phase 2, Open-Label Trial to Evaluate Safety of Epcoritamab Monotherapy in Subjects with Relapsed or Refractory Diffuse Large B-Cell Lymphoma and Classic Follicular Lymphoma (Previously Grade 1-3a) when Administered in the Outpatient Setting |
|
PSCI-22-063 |
NRG-GU011: A Phase II Double-Blinded, Placebo-Controlled Trial of PROstate OligoMETastatic RadiotHErapy With or Without ANdrogen Deprivation Therapy in Oligometastatic Prostate Cancer (NRG Promethean) |
|
PSCI-22-066 |
A Phase 3 Randomized, Open-Label, Multicenter Study Evaluating the Efficacy of Axicabtagene Ciloleucel Versus Standard of Care Therapy in Subjects with Relapsed/Refractory Follicular Lymphoma |
|
PSCI-22-070 |
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease (CIRCULATE-US) (NRG-GI008) |
|
PSCI-22-082 |
A Phase 3 Open-label, Randomised Study of Datopotamab Deruxtecan (Dato-DXd) With or Without Durvalumab Versus Investigator's Choice of Therapy in Patients With Stage I-III Triple-negative Breast Cancer Who Have Residual Invasive Disease in the Breast and/or Axillary Lymph Nodes at Surgical Resection Following Neoadjuvant Systemic Therapy(TROPION-Breast03) |
|
PSCI-22-084 |
Exercise intervention coupled with standard post-cancer directed treatment care to reduce chronic pain in childhood cancer survivors who have completed cancer- directed therapy less than one year |
|
PSCI-22-088 |
Exercise intervention coupled with standard post-cancer directed treatment care to reduce chronic pain in adolescents and young adult cancer survivors who have completed cancer-directed therapy less than one year |
